Zolpidem Brand Names
Zolpidem is marketed under several brand names, most commonly Ambien, with other formulations including Ambien CR (extended-release), Edluar (sublingual), Zolpimist (oral spray), and Intermezzo (low-dose sublingual). 1
Available Formulations
The FDA-approved brand name products containing zolpidem include:
- Ambien - Immediate-release tablets (the original and most widely prescribed formulation) 2
- Ambien CR - Extended-release formulation 1
- Edluar - Sublingual tablet formulation 1
- Zolpimist - Oral spray formulation (approved 2008, uses NovaMist spray technology with 5 mg per metered spray) 3
- Intermezzo - Low-dose sublingual formulation for middle-of-the-night awakenings 1
- Stilnox - Brand name used internationally (particularly in Europe and other markets) 2, 4
- Myslee - Another international brand name 2
Clinical Context
Zolpidem is classified as a federally controlled substance (Schedule C-IV) due to abuse and dependence potential 1. It is a non-benzodiazepine benzodiazepine receptor agonist (BzRA) that accounts for approximately 87.5% of all BzRA prescriptions, making it the most widely prescribed hypnotic medication in the United States 5.
The generic formulation is simply labeled as zolpidem tartrate and is widely available 1.